SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 1 — Calamity Jane

PatientMartha Canary
Date of birth1981-05-01
IdentifiersMRN HR-NI008-SYN; SSN (made up) 000-08-9532
Document date2026-03-02
AuthorRuth Ann Kessler, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Subjective

The patient attends this visit for establishing primary care for heavy daily drinking: a nonjudgmental, trauma-informed assessment, withdrawal risk and outpatient withdrawal management, thiamine, liver tests, nutrition, mood and safety, and housing, food and income. [S]

Objective

White blood cells: 6.8 10*3/uL; Hemoglobin: 12.1 g/dL; MCV: 103 fL (high); Platelets: 162 10*3/uL; Sodium: 134 mmol/L (low); Potassium: 3.3 mmol/L (low); Creatinine: 0.62 mg/dL; eGFR (CKD-EPI 2021): 113 mL/min/1.73 m²; Glucose: 78 mg/dL; Magnesium: 1.5 mg/dL (low); Phosphate: 2.4 mg/dL (low); Albumin: 3.4 g/dL (low); Total bilirubin: 1.1 mg/dL; INR: 1; AST: 96 U/L (high); ALT: 44 U/L (high); GGT: 240 U/L (high); Folate: 3.2 ng/mL (low); Vitamin B12: 410 pg/mL; PEth: 820 ng/mL (high); AUDIT: 31; PHQ-9: 14; GAD-7: 11; PC-PTSD-5: 2. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-03-02Body height165cmS
2026-03-02Body weight50kgS
2026-03-02Body mass index (BMI) [Ratio]18.4kg/m2S
2026-03-02Systolic blood pressure146mm[Hg]S
2026-03-02Diastolic blood pressure92mm[Hg]S
2026-03-02Heart rate104/minS
2026-03-02Respiratory rate18/minS
2026-03-02Body temperature37.2CelS
2026-03-02Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-02Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2026-03-02Hemoglobin [Mass/volume] in Blood12.1g/dL12-15.5 g/dLNormalS
2026-03-02MCV [Entitic mean volume] in Red Blood Cells by Automated count103fL80-100 fLHighS
2026-03-02Platelets [#/volume] in Blood by Automated count16210*3/uL150-400 10*3/uLNormalS
2026-03-02Sodium [Moles/volume] in Serum or Plasma134mmol/L135-145 mmol/LLowS
2026-03-02Potassium [Moles/volume] in Serum or Plasma3.3mmol/L3.5-5.1 mmol/LLowS
2026-03-02Creatinine [Mass/volume] in Serum or Plasma0.62mg/dL0.59-1.04 mg/dLNormalS
2026-03-02Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M113mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-02Glucose [Mass/volume] in Serum or Plasma78mg/dL70-99 mg/dLNormalS
2026-03-02Magnesium [Mass/volume] in Serum or Plasma1.5mg/dL1.7-2.3 mg/dLLowS
2026-03-02Phosphate [Mass/volume] in Serum or Plasma2.4mg/dL2.5-4.5 mg/dLLowS
2026-03-02Albumin [Mass/volume] in Serum or Plasma3.4g/dL3.5-5 g/dLLowS
2026-03-02Bilirubin.total [Mass/volume] in Serum or Plasma1.1mg/dL<=1.2 mg/dLNormalS
2026-03-02INR in Platelet poor plasma by Coagulation assay1{INR}0.9-1.1NormalS
2026-03-02Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma96U/L10-35 U/LHighS
2026-03-02Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma44U/L7-35 U/LHighS
2026-03-02Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma240U/L5-40 U/LHighS
2026-03-02Folate [Mass/volume] in Serum or Plasma3.2ng/mL>=4 ng/mLLowS
2026-03-02Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma410pg/mL200-900 pg/mLNormalS
2026-03-02Phosphatidylethanol [Mass/volume] in Blood820ng/mL<=20 ng/mLHighS
2026-03-02Total score [AUDIT]31{score}S
2026-03-02Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
2026-03-02Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]11{score}S
2026-03-02PC-PTSD-5 score [PC-PTSD-5]2{score}S

Medications

MedicationFrequencyRouteDatesStatusEvidence
Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days onlyPer the written five-day scheduleOral route2026-03-02 to 2026-03-06completedS
Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic100 mg intramuscularly once daily for three daysIntramuscular route2026-03-02 to 2026-03-04completedS
Folic acid 1 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-03-02activeS
Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five daysOne tablet daily with food for five daysOral route2026-03-02 to 2026-03-06completedS
Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeksOne tablet twice daily for two weeksOral route2026-03-02 to 2026-03-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis.
Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checksactiveconfirmed F10.230S — Synthetic withdrawal episode; resolved by the one-week visit.
Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement plannedactiveconfirmed R74.01S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease.
Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcoholactiveprovisional F32.AS — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood.
Daily chewing tobacco for many years; not ready to stop at intakeactiveconfirmed F17.220S — Synthetic modern coding anchored to the documented chewing tobacco.
Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albuminactiveconfirmed R63.6S — Synthetic finding anchored to a contemporary impression of poor nutrition (R).
Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past wintersactiveconfirmed Z59.811S — Synthetic social need anchored to her documented poverty and moves from town to town.
Food insecurity: often goes without meals at the end of the monthactiveconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.

Assessment

Plan of Treatment